These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

573 related articles for article (PubMed ID: 31213789)

  • 1. Decline in FEV
    Hiller AM; Piitulainen E; Jehpsson L; Tanash H
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1075-1083. PubMed ID: 31213789
    [No Abstract]   [Full Text] [Related]  

  • 2. Individualized lung function trends in alpha-1-antitrypsin deficiency: a need for patience in order to provide patient centered management?
    Stockley RA; Edgar RG; Pillai A; Turner AM
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1745-56. PubMed ID: 27536086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exacerbations and duration of smoking abstinence are associated with the annual loss of FEV
    Fähndrich S; Bernhard N; Lepper PM; Vogelmeier C; Seibert M; Wagenpfeil S; Bals R
    Respir Med; 2017 Aug; 129():8-15. PubMed ID: 28732839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term evolution of lung function in individuals with alpha-1 antitrypsin deficiency from the Spanish registry (REDAAT).
    Esquinas C; Serreri S; Barrecheguren M; Rodriguez E; Nuñez A; Casas-Maldonado F; Blanco I; Pirina P; Lara B; Miravitlles M
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1001-1007. PubMed ID: 29615836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deterioration of quality of life is associated with the exacerbation frequency in individuals with alpha-1-antitrypsin deficiency - analysis from the German Registry.
    Bernhard N; Lepper PM; Vogelmeier C; Seibert M; Wagenpfeil S; Bals R; Fähndrich S
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1427-1437. PubMed ID: 28553095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung transplantation and survival outcomes in patients with oxygen-dependent COPD with regard to their alpha-1 antitrypsin deficiency status.
    Ekström M; Tanash H
    Int J Chron Obstruct Pulmon Dis; 2017; 12():3281-3287. PubMed ID: 29158672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of lung disease in alpha-1 antitrypsin deficiency: a systematic review.
    Edgar RG; Patel M; Bayliss S; Crossley D; Sapey E; Turner AM
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1295-1308. PubMed ID: 28496314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health status and lung function in the Swedish alpha 1-antitrypsin deficient cohort, identified by neonatal screening, at the age of 37-40 years.
    Piitulainen E; Mostafavi B; Tanash HA
    Int J Chron Obstruct Pulmon Dis; 2017; 12():495-500. PubMed ID: 28203073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do frequent moderate exacerbations contribute to progression of chronic obstructive pulmonary disease in patients who are ex-smokers?
    Dreyse J; Díaz O; Repetto PB; Morales A; Saldías F; Lisboa C
    Int J Chron Obstruct Pulmon Dis; 2015; 10():525-33. PubMed ID: 25792820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Clinical Profile of Subjects Included in the Swedish National Register on Individuals with Severe Alpha 1-Antitrypsin deficiency.
    Piitulainen E; Tanash HA
    COPD; 2015 May; 12 Suppl 1():36-41. PubMed ID: 25938290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Clinical Course of Severe Alpha-1-Antitrypsin Deficiency in Patients Identified by Screening.
    Hiller AM; Piitulainen E; Tanash H
    Int J Chron Obstruct Pulmon Dis; 2022; 17():43-52. PubMed ID: 35023912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maximal mid-expiratory flow detects early lung disease in α
    Stockley JA; Ismail AM; Hughes SM; Edgar R; Stockley RA; Sapey E
    Eur Respir J; 2017 Mar; 49(3):. PubMed ID: 28356373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decline in FEV1 related to smoking status in individuals with severe alpha1-antitrypsin deficiency (PiZZ).
    Piitulainen E; Eriksson S
    Eur Respir J; 1999 Feb; 13(2):247-51. PubMed ID: 10065663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of smoke exposure on the clinical phenotype of alpha-1 antitrypsin deficiency in Ireland: exploiting a national registry to understand a rare disease.
    O'Brien ME; Pennycooke K; Carroll TP; Shum J; Fee LT; O'Connor C; Logan PM; Reeves EP; McElvaney NG
    COPD; 2015 May; 12 Suppl 1():2-9. PubMed ID: 25938284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term prognosis of asthma, chronic obstructive pulmonary disease, and asthma-chronic obstructive pulmonary disease overlap in the Copenhagen City Heart study: a prospective population-based analysis.
    Lange P; Çolak Y; Ingebrigtsen TS; Vestbo J; Marott JL
    Lancet Respir Med; 2016 Jun; 4(6):454-62. PubMed ID: 27061878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinase-9 predicts pulmonary status declines in α1-antitrypsin deficiency.
    Omachi TA; Eisner MD; Rames A; Markovtsova L; Blanc PD
    Respir Res; 2011 Mar; 12(1):35. PubMed ID: 21429222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensive smoking diminishes the differences in quality of life and exacerbation frequency between the alpha-1-antitrypsin deficiency genotypes PiZZ and PiSZ.
    Bernhard N; Lepper PM; Vogelmeier C; Seibert M; Wagenpfeil S; Bals R; Fähndrich S
    Respir Med; 2017 Sep; 130():1-8. PubMed ID: 29206626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The phenotype of concurrent chronic bronchitis and frequent exacerbations in patients with severe COPD attending Swedish secondary care units.
    Sundh J; Johansson G; Larsson K; Lindén A; Löfdahl CG; Sandström T; Janson C
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2327-34. PubMed ID: 26604732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease.
    Dransfield MT; Kunisaki KM; Strand MJ; Anzueto A; Bhatt SP; Bowler RP; Criner GJ; Curtis JL; Hanania NA; Nath H; Putcha N; Roark SE; Wan ES; Washko GR; Wells JM; Wendt CH; Make BJ;
    Am J Respir Crit Care Med; 2017 Feb; 195(3):324-330. PubMed ID: 27556408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endobronchial coil treatment in severe emphysema patients with alpha-1 antitrypsin deficiency.
    Perotin JM; Leroy S; Marquette CH; Mal H; Dutau H; Bourdin A; Vergnon JM; Pison C; Barbe C; Deslee G;
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3645-3649. PubMed ID: 30464447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.